Lv11
56 积分 2025-04-22 加入
Bispecific T cell engager therapy for refractory rheumatoid arthritis
5小时前
待确认
Achievable but elusive: LLDAS and DORIS remission in clinical trials of belimumab
6小时前
已完结
BCMA-Targeted T-Cell–Engager Therapy for Autoimmune Disease
6小时前
已完结
MTX use in the treatment of RA-associated-interstitial lung disease: a systematic review
1个月前
已完结
Nanozyme-driven remodeling of the immune microenvironment: from catalytic therapy to precise immune regulation
1个月前
已完结
Polymer‐Encapsulated Catalase for Targeted Redox Regulation in Acute Liver Injury
1个月前
已完结
Comparative Effectiveness of Tocilizumab vs Rituximab in Rheumatoid Arthritis-Associated Interstitial Lung Disease
2个月前
已完结
Comparative Effectiveness of Tocilizumab vs Rituximab in Rheumatoid Arthritis-Associated Interstitial Lung Disease
3个月前
已关闭
Comparative Effectiveness of Tocilizumab vs Rituximab in Rheumatoid Arthritis-Associated Interstitial Lung Disease
4个月前
已关闭
BCMA T-Cell Engager Therapy in Patients with Refractory Autoimmune Disease
5个月前
已完结
皖公网安备34019202002308
